Couple of queries ...
Does anyone know when the first milestone payment is due to NEU?
For example, is it when the initial results of the phase 3 are published? ...
That would maybe be 12 months from now ... yes/no?
And I quote from the recent Arcadia results from the link a couple of posts back ....
GAAP R&D is expected to be between $250 million and $265 million. The increase compared to 2018 reflects the planned progression of five late-stage clinical programs in 2019..... unquote.
Two things ... there is actrually no mention in the commentary about Fragile X going to Phase 3 trial... Little T... where did you hear this? ... not saying you are wrong ... just asking ...
Also ... Arcadia will have to start the process of capital raising a year from now ... although of course at that time they might be able to point to several successful phase 3 results which will help a lot, they may want to take Neuren over (say US$1billion) but even so there will be milestone payments to make to Neuren ... assuming Phase 3 success of course.
Couple of queries ... Does anyone know when the first milestone...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.000(0.00%) |
Mkt cap ! $2.552B | |||
| Open | High | Low | Value | Volume |
| $19.96 | $19.97 | $19.69 | $4.156M | 209.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 246 | $19.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 512 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |